Clinical Trial Update: Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects [Phase 1]

View source ↗

Summary

Phase 1 safety and tolerability study of RCT1100 in healthy individuals and patients with primary ciliary dyskinesia has completed, reporting on its safety prof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ciliary Dyskinesia

Drugs mentioned

• RCT1100

Snippet

Sponsor: ReCode Therapeutics | Conditions: Primary Ciliary Dyskinesia | Phase 1 | Status: COMPLETED